EHRA Premium Access

Myocardial damage as a result of implantation and defibrillation testing in transvenous and subcutaneous implantable cardioverter-defibrillators.

Topic: Implantable Cardioverter-Defibrillator (ICD)

Congress Presentation

About the speaker

Doctor Anne-Floor Barbara Eleonore Quast

Academic Medical Centre, Amsterdam (Netherlands (The))
0 follower

9 more presentations in this session

Refining ICD decision-making in non-ischaemic patients in the post-DANISH era: analysis from a nationwide database of daily remote-monitoring transmissions in a real-world cohort

Speaker: Doctor G. Forleo (Milano, IT)


Long-term performance of contemporary internal cardioverter defibrillator leads: a single center experience

Speaker: Doctor R. Brenner (St. Gallen, CH)


Incidence of appropriate therapy and mortality after ICD generator replacement: results from a real-world nationwide prospective cohort

Speaker: Doctor M. Ruwald (Hellerup, DK)


Depression and anxiety during the first 12 months post-implant: a matched cohort study of patients with a subcutaneous implantable defibrillator and patients with a transvenous system

Speaker: Professor S. Schmidt Pedersen (Odense, DK)


Predictors of acute effectiveness of subcutaneous implantable cardioverter-defibrillator according to the implantation technique

Speaker: Doctor P. Francia (Rome, IT)


Access the full session

Rapid Fire 4: The shocking truth of device therapy

Speakers: Doctor A. Quast, Doctor G. Forleo, Doctor R. Brenner, Doctor M. Ruwald, Professor S. Schmidt Pedersen...

About the event


EHRA 2019

17 March - 19 March 2019

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb